Aliskiren: all 132 studies that test it

Page 2 of 2. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.

• Time Course of the Antiproteinuric and Blood Pressure Lowering Effects After Initiation of Renin Inhibition With Aliskiren in Type 2 DiabetesCompletedNCT00461136Phase 1/2
• Pharmacokinetic and Pharmacodynamic Profiles of Aliskiren in Japanese Patients With Mild to Moderate Essential HypertensionCompletedNCT00424541Phase 1
• Bioavailability of Aliskiren and Valsartan as a Single Tablet vs. the Same Doses of the Two Drugs Given Separately to Healthy Subjects.CompletedNCT00416728Phase 1
• Bioavailability of Aliskiren and Valsartan Combined as a Single Tablet vs. the Same Medications Given Separately to Healthy Subjects.CompletedNCT00416468Phase 1
• Safety/Efficacy of Combo Therapy With Aliskiren & Hydrochlorothiazide vs Therapy With Hydrochlorothiazide Alone in Patients With HypertensionCompletedNCT00387517Phase 3
• A Safety and Efficacy Trial of the Combination of Aliskiren / Hydrochlorothiazide (HCTZ)(300/12.5 mg and 300/25 mg) Compared to Aliskiren 300 mg in Hypertensive PatientsCompletedNCT00386139Phase 3
• Study Comparing SPP100 (Aliskiren) 150mg to Placebo and to Losartan 50mg in Patients With Mild to Moderate Essential HypertensionCompletedNCT00344110Phase 3
• Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension.CompletedNCT00343551Phase 3
• SPP100 Dose Finding Study in JapanCompletedNCT00311012Phase 2
• SPP100 (Aliskiren) Regimen in Hypertensive Patients With Renal DysfunctionCompletedNCT00299832Phase 3
• SPP100 (Aliskiren) Regimen in Patients With Severe HypertensionCompletedNCT00299806Phase 3
• A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazide Based Treatment Regimen With Optional Addition of AmlodipineCompletedNCT00294710Phase 3
• Efficacy and Safety of Aliskiren and Atenolol in Adults (>18) With Mild to Moderate HypertensionCompletedNCT00262236Phase 3
• A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren in Patients With High Blood PressureCompletedNCT00260923Phase 3
• A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is Not Recruiting in the US)CompletedNCT00246584Phase 2
• Treatment of Supine Hypertension in Autonomic FailureCompletedNCT00223717Phase 1
• A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Valsartan in Hypertensive Non Responders PatientsCompletedNCT00219193Phase 3
• Clinical Study to Evaluate Efficacy and Safety of Aliskiren (150mg & 300mg) Administered Alone and in Combo With Valsartan (160mg and 320mg) in Patients With High Blood PressureCompletedNCT00219180Phase 3
• A Clinical Study to Assess Efficacy and Safety of Aliskiren in the Elderly With High Blood PressureCompletedNCT00219167Phase 3
• A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazidebased Treatment Regimen With Optional Addition of AmlodipineCompletedNCT00219154Phase 3
• A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren 150mg, 300mg, and 600mg to Placebo in Patients With High Blood Pressure.CompletedNCT00219128Phase 3
• A Clinical Study to Compare Combination of Aliskiren+ HCTZ to Irbesartan+ HCTZ or Amlodipine+ HCTZ or HCTZ Alone in Obese Hypertensive Not Responsive to HCTZ 25 mgCompletedNCT00219115Phase 3
• A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder PatientsCompletedNCT00219102Phase 3
• A Clinical Study to Evaluate the Safety and Efficacy of Aliskiren Alone and in Combination With Ramipril in Hypertensive, Diabetic Patients.CompletedNCT00219089Phase 3
• A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Amlodipine in Hypertensive Non Responders PatientsCompletedNCT00219076Phase 3
• A Clinical Study to Compare an Aliskiren Based Hypertensive Regimen With a Ramipril Based One Followed by a Randomized Withdrawal.CompletedNCT00219063Phase 3
• A Clinical Study to Compare the Safety and Efficacy of an Aliskiren-based Regimen With a Lisinopril Based Regimen in Patients With Severe HypertensionCompletedNCT00219050Phase 3
• Long Term Safety of Aliskiren Alone or With the Optional Addition of Hydrochlorothiazide in Patients With Essential HypertensionCompletedNCT00219037Phase 3
• Clinical Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension.CompletedNCT00219024Phase 3
• "ALOFT - Aliskiren Observation of Heart Failure Treatment": Efficacy and Safety of Aliskiren Added on Top of Standard Therapy in Adults (≥ 18 Years) With Stable Heart FailureCompletedNCT00219011Phase 3
• A Clinical Study to Evaluate the Long-term Safety (12 Months) of the Combination of Aliskiren 300 mg and Hydrochlorothiazide 25 mgCompletedNCT00171405Phase 3
• Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and ProteinuriaCompletedNCT00097955Phase 2

← Aliskiren overview